133 Molesworth Street
PO Box 5013
Wellington 6140
New Zealand
T+64 4 496 2000
11 April 2022
Peter Russell
By email
[FYI request #18517 email]
Ref
H202203851
Tēnā koe Peter
Transfer of your request for official information
Thank you for your request under the Official Information Act 1982 (the Act) to the Ministry of
Health (the Ministry) on 12 March 2022 for:
“I request copies of any and all advice received by the government regarding how it can
manage public perceptions and concerns about the SARS-CoV-2 "vaccine"
The Ministry believes your request are more closely connected with the functions of the
Department of the Prime Minister and Cabinet (DPMC). For this reason, I have decided to
transfer your full request as indicated above to DPMC under section 14(b)(ii) of the Act. You
can expect a response to your request from DPMC in due course.
Please accept our apologies for the delay in communicating a decision on your request. Under
section 28(3) of the Act, you have the right to ask the Ombudsman to review my decision to
partially transfer your request. The Ombudsman may be contacted by email at:
[email address] or by calling 0800 802 602.
Nāku noa, nā
Jan Torres
Acting Manager, OIA Services
Office of the Director-General
Copy of OIA request
From: [FYI request #18517 email]
Sent: Saturday, 12 March 2022 09:54
To: OIA Requests
[email address] Subject: Your request for official information (H202201229)
Dear OIA Requests,
Your message of 24 February 2022 asked "Are you able to please clarify to what you mean?"
Although I feel the original question is simple enough that it should not require clarification, I will
attempt to do so. I asked for copies of any and all advice received by the government regarding
how public perception and concerns about potential or actual SARS-Cov-2/COVID-19 "vaccine"
related side effects, adverse reactions, injuries and deaths can or should be managed.
I request copies of any and all advice received by the government regarding how it can manage
public perceptions and concerns about the SARS-CoV-2 "vaccine" (as described above).
Yours sincerely,
Peter Russell
Page 2 of 2
